MYRIAD GENETICS INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Myriad Genetics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q4 2024.
  • Myriad Genetics Inc Operating Income (Loss) for the quarter ending December 31, 2024 was -$39.1M, a 24.5% decline year-over-year.
  • Myriad Genetics Inc Operating Income (Loss) for the twelve months ending December 31, 2024 was -$124M, a 52% increase year-over-year.
  • Myriad Genetics Inc annual Operating Income (Loss) for 2024 was -$124M, a 52% increase from 2023.
  • Myriad Genetics Inc annual Operating Income (Loss) for 2023 was -$257M, a 83.1% decline from 2022.
  • Myriad Genetics Inc annual Operating Income (Loss) for 2022 was -$141M, a 26.2% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$124M -$39.1M -$7.7M -24.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 -$116M -$20M +$40.1M +66.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$156M -$36.5M +$77.2M +67.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$233M -$27.9M +$24.3M +46.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$257M -$31.4M +$20.8M +39.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 -$278M -$60.1M -$15.1M -33.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$263M -$114M -$95.9M -539% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$167M -$52.2M -$26.6M -104% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$141M -$52.2M -$9.1M -21.1% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 -$132M -$45M +$34.9M +43.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$166M -$17.8M +$3M +14.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$169M -$25.6M +$21.1M +45.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$191M -$43.1M +$5.1M +10.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$196M -$79.9M -$40.3M -102% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$155M -$20.8M +$47.5M +69.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$203M -$46.7M +$87M +65.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$290M -$48.2M -$39.4M -448% Oct 1, 2020 Dec 31, 2020 10-KT 2021-03-16
Q3 2020 -$250M -$39.6M -$18.7M -89.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$232M -$68.3M -$62.7M -1120% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$169M -$134M -$140M -2366% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$29.4M -$8.8M -$14.9M -244% Oct 1, 2019 Dec 31, 2019 10-KT 2021-03-16
Q3 2019 -$14.5M -$20.9M -$22.1M -1842% Jul 1, 2019 Sep 30, 2019 10-KT 2021-03-16
Q2 2019 $7.6M -$5.6M -$23.4M -131% Apr 1, 2019 Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $31M $5.9M -$7.9M -57.2% Jan 1, 2019 Mar 31, 2019 10-KT 2021-03-16
Q4 2018 $38.9M $6.1M -$200K -3.18% Oct 1, 2018 Dec 31, 2018 10-KT 2021-03-16
Q3 2018 $39.1M $1.2M -$82.8M -98.6% Jul 1, 2018 Sep 30, 2018 10-KT 2021-03-16
Q2 2018 $122M $17.8M -$1.1M -5.82% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-13
Q1 2018 $123M $13.8M +$8.3M +151% Jan 1, 2018 Mar 31, 2018 10-K 2019-08-13
Q4 2017 $115M $6.3M -$10.9M -63.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-08-13
Q3 2017 $126M $84M +$76.9M +1083% Jul 1, 2017 Sep 30, 2017 10-K 2019-08-13
Q2 2017 $48.7M $18.9M -$3.4M -15.2% Apr 1, 2017 Jun 30, 2017 10-K 2018-08-24
Q1 2017 $52.1M $5.5M -$37.1M -87.1% Jan 1, 2017 Mar 31, 2017 10-K 2018-08-24
Q4 2016 $89.2M $17.2M -$28M -61.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-08-24
Q3 2016 $117M $7.1M -$36.2M -83.6% Jul 1, 2016 Sep 30, 2016 10-K 2018-08-24
Q2 2016 $153M $22.3M -$13.4M -37.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-24
Q1 2016 $167M $42.6M +$6.9M +19.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $160M $45.2M +$8.9M +24.5% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $151M $43.3M +$17.4M +67.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $134M $35.7M -$17.5M -32.9% Apr 1, 2015 Jun 30, 2015 10-K 2018-08-24
Q1 2015 $151M $35.7M -$19.6M -35.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $171M $36.3M -$46.7M -56.3% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-03
Q3 2014 $217M $25.9M -$57M -68.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $274M $53.2M -$12.7M -19.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-10
Q1 2014 $287M $55.3M -$2.63M -4.54% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $290M $83M +$27.4M +49.3% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
Q3 2013 $262M $82.9M +$34.3M +70.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $228M $65.9M +$18.6M +39.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-12
Q1 2013 $209M $57.9M +$11.8M +25.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $198M $55.6M +$10.1M +22.3% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-05
Q3 2012 $187M $48.6M +$7.11M +17.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $180M $47.3M +$5.51M +13.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-13
Q1 2012 $175M $46.1M +$4.27M +10.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $171M $45.5M +$6.88M +17.8% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-06
Q3 2011 $164M $41.5M +$5.88M +16.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $158M $41.8M Apr 1, 2011 Jun 30, 2011 10-K 2013-08-14
Q1 2011 $41.8M +$8.6M +25.9% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q4 2010 $38.6M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-01
Q3 2010 $35.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q1 2010 $33.2M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.